DaVita
DVA
#1914
Rank
NZ$18.61 B
Marketcap
NZ$295.95
Share price
4.09%
Change (1 day)
44.24%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$24.31

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$25.26. In 2025 the company made an earnings per share (EPS) of NZ$18.42 a decrease over its 2024 EPS that were of NZ$20.07.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$24.3132%
2025NZ$18.42-8.25%
2024NZ$20.0744.94%
2023NZ$13.8527.26%
2022NZ$10.88-35.56%
2021NZ$16.8944.1%
2020NZ$11.7219.7%
2019NZ$9.79540.48%
2018NZ$1.53-76.07%
2017NZ$6.39-19.31%
2016NZ$7.92242.52%
2015NZ$2.31-62.87%
2014NZ$6.2213.43%
2013NZ$5.498.45%
2012NZ$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$43.97 74.06%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$22.33-11.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$63.17 150.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.43-86.41%๐Ÿ‡บ๐Ÿ‡ธ USA